|
1 Indications And Usage Qsymia Is Indicated As An Adjunct To A Reduced-Calorie Diet And Increased Physical Activity For Chronic Weight Management In Adult Patients With An Initial Body Mass Index (Bmi) Of 30 Kg/m 2 Or Greater (Obese), Or 27 Kg/m 2 Or Greater (Overweight) In The Presence Of At Least One Weight Related Comorbidity Such As Hypertension, Type 2 Diabetes Mellitus, Or Dyslipidemia Qsymia Is A Combination Of Phentermine, A Sympathomimetic Amine Anorectic, And Topiramate Extended-Release, An Antiepileptic Drug, Indicated As An Adjunct To A Reduced-Calorie Diet And Increased Physical Activity For Chronic Weight Management In Adults With An Initial Body Mass Index (Bmi) Of: 30 Kg/m 2 Or Greater (Obese) ( 1 ) Or 27 Kg/m 2 Or Greater (Overweight) In The Presence Of At Least One Weight-Related Comorbidity Such As Hypertension, Type 2 Diabetes Mellitus, Or Dyslipidemia ( 1 ) Limitations Of Use: The Effect Of Qsymia On Cardiovascular Morbidity And Mortality Has Not Been Established ( 1 ). The Safety And Effectiveness Of Qsymia In Combination With Other Products Intended For Weight Loss, Including Prescription And Over-The-Counter Drugs, And Herbal Preparations, Have Not Been Established ( 1 ). Limitations Of Use The Effect Of Qsymia On Cardiovascular Morbidity And Mortality Has Not Been Established. The Safety And Effectiveness Of Qsymia In Combination With Other Products Intended For Weight Loss, Including Prescription And Over-The-Counter Drugs And Herbal Preparations Have Not Been Established.
|